Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Extension Clinical Study to Evaluate the Long-term Efficacy and Safety of Repeat Treatment of YVOIRE Contour Injected Into the Anteromedial Malar Region in Subjects Who Have Completed the LG-HACL014 Study

NCT02119793 is registered in ClinicalTrials.gov with LG Life Sciences as lead sponsor.

NCT NCT02119793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02119793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Extension Clinical Study to Evaluate the Long-term Efficacy and Safety of Repeat Treatment of YVOIRE Contour Injected Into the Anteromedial Malar Region in Subjects Who Have Completed the LG-HACL014 Study
Lead sponsor
LG Life Sciences
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
August 31, 2016
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

normal, healthy adults with moderate, severe, or very severe volume loss of anteromedial malar region who have completed the lg-hacl014 study